Skip to main content

NEW MALARIA DRUG - TREAT, PROTECTS AND PREVENTS ITS SPREAD

Mosquito bite
Researchers at Dundee University have discovered a new compound which could treat malaria while protecting people from the disease and preventing its spread, all in a single dose.
The compound, DDD107498, was developed by the university's Drug Discovery Unit and the Medicines for Malaria Venture.
Scientists said the "exciting" new drug could work well against parasites resistant to current treatments.
Details of the discovery have been published in the journal Nature.
The World Health Organisation reported 200 million clinical cases of malaria in 2013, with 584,000 people dying from the mosquito-borne disease, most of them pregnant women or children under five.
Concerns have been growing about strains of malaria which are resistant to current treatments, which have already appeared on the border between Myanmar and India.

'Real threat'

Dr Kevin Read, joint leader of the project, said new drugs were "urgently needed".
He said: "Resistance to the current gold-standard anti-malarial drug is now considered a real threat.
"The compound we have discovered works in a different way to all other anti-malarial medicines on the market or in clinical development, which means that it has great potential to work against current drug-resistant parasites.
"It targets part of the machinery that makes proteins within the parasite that causes malaria."

Dr David Reddy, CEO of MMV, added: "Malaria continues to threaten almost half of the world's population - the half that can least afford it.
"DDD107498 is an exciting compound since it holds the promise to not only treat but also protect these vulnerable populations."
The university has been working with MMV since 2009 to identify new treatments for the disease. The project was initiated by testing a collection of about 4,700 compounds at the Drug Discovery Unit (DDU), to see if any would kill the malaria parasite.
This provided the chemical starting-point for the new compound, which was optimised through cycles of design, preparation and testing.
The compound is now undergoing safety testing through MMV, with a view to entering human clinical trials within the next year.
Prof Ian Gilbert, head of chemistry at the DDU, who led the team which discovered the compound, said he was "very excited" by the progress made.
He said: "The publication reveals that DDD107498 has the potential to treat malaria with a single dose, prevent the spread of malaria from infected people, and protect a person from developing the disease in the first place."
Labels:

Comments

Post a Comment

I will like to hear your comments. Please leave a comment below

Popular posts from this blog

Shed Yuletide Pound. Cabbage soup diet: Quick results?

The cabbage soup diet, like most radical short-term diets, is not for everyone. Eating little but cabbage soup for seven days can produce amazing results, but it can also leave you feeling groggy, sluggish and unsatisfied. That said, if you’re looking to shed those holiday pounds or lose weight quickly before an important event, the cabbage soup diet promises a 10-pound weight loss in just one week. Success on the cabbage soup diet depends largely on the individual. Some may feel alienated by the boring and unappealing food selection, but others may find quick results to be motivating. It’s important to note that crash diets like this are not without health risks and should only be attempted under professional advisement. How it works With the cabbage soup diet, there is no calorie or carb counting and no recommended exercise regimen or lifestyle changes. Instead, the diet is based on a seven-day menu centered almost exclusively on a special cabbage-based s
Post a Comment
Read more

Obesity 'biggest threat to women's health

Obesity is the biggest threat to women's health and the health of future generations, warns England's chief medical officer Dame Sally Davies. Her annual report , which focuses on women this year, said tackling obesity should be a national priority to avert a "growing health catastrophe". She said the food industry needed to do more or it should face a sugar tax. Dame Sally is also calling for better treatment of ovarian cancer and more open discussion on incontinence. England's top doctor said obesity was so serious it should be a priority for the whole population, but particularly for women because too often it shortened their lives. In England in 2013, 56.4% of women aged 34-44 and 62% of women aged 45-54 were classified as overweight or obese. Obesity increases the risk of many diseases including breast cancer, type 2 diabetes and heart disease. Sugar tax Dame Sally warned that if the food
Post a Comment
Read more

Bladder Incontinence: Suffering in Silence

Urinary incontinence is leaking of urine that you can't control. Many men and women suffer from urinary incontinence. We don't know for sure exactly how many. That's because many people do not tell anyone about their symptoms. They may be embarrassed, or they may think nothing can be done. So they suffer in silence. Urinary incontinence is not just a medical problem. It can affect emotional, psychological and social life. Many people who have urinary incontinence are afraid to do normal daily activities. They don't want to be too far from a toilet. Urinary incontinence can keep people from enjoying life. Many people think urinary incontinence is just part of getting older. But it's not. And it can be managed or treated. Learn more here. Talk to your doctor. Find out what treatment is best for you. Key Statistics A quarter to a third of men and women in the U.S. suffer from urinary incontinence. That means millions of Americans. About 33 million have
Post a Comment
Read more